Burosumab

Immunoglobulin G1, anti-(human fibroblast growth factor 23) (human monoclonal KRN23 heavy chain), disulfide with human monoclonal KRN23 light chain, dimer

Stoffgruppe

Mittel bei Hypophosphatämie